ResearcherShanghai Medical College of Fudan UniversityNo recent work listed
Dexiang Zhang
Matched on ORCID iD 0009-0008-7144-3761; OpenAlex author ID A5069860925. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper
Papers 4
- TFCP2 Overcomes Senescence by Cooperating With SREBP2 to Activate Cholesterol Synthesis in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.724437↗
- PEBP4 promoted the growth and migration of cancer cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13277-015-3906-0↗
- KLF2 is downregulated in pancreatic ductal adenocarcinoma and inhibits the growth and migration of cancer cells. Co-author DOI 10.1007/s13277-015-4053-3↗
- Prognostic factors in patients with pancreatic cancer. Co-author DOI 10.3892/etm.2011.412↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuedi Dai · 4 shared papers, 2012–2021 · strength 0.34
- Paper TFCP2 Overcomes Senescence by Cooperating With SREBP2 to Activate Cholesterol Synthesis in Pancreatic Cancer. DOI 10.3389/fonc.2021.724437↗
- Paper PEBP4 promoted the growth and migration of cancer cells in pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-3906-0↗
- Paper KLF2 is downregulated in pancreatic ductal adenocarcinoma and inhibits the growth and migration of cancer cells. DOI 10.1007/s13277-015-4053-3↗
- Houbao Liu · 1 shared paper, 2016 · strength 0.06
- Han Liu · 1 shared paper, 2016 · strength 0.06
- Houbao Liu · 1 shared paper, 2016 · strength 0.06
- Tao Li · 1 shared paper, 2012 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.